Basic Information
| RNALocate ID: | RLID:01002022 |
| RNA Symbol: | hsa-miR-363-3p |
| Localization: | Mitochondrion |
RNA Information
| RNA Name: | hsa-miR-363 |
| RNA ID: | miRBase:MIMAT0000707 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 22984580 |
| Tissue/Cell Line: | Cell line (HEK-293) |
| Method: | Next-generation RNA sequencing |
| Description: | The differential association of miRNA to mitochondria of both HEK293 and HeLa has been summarized in Table S3. Data are collected from Table S3: Pattern of miRNAs associated with mitochondria of HEK293 and HeLa. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002021 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:11002435 | Exosome | Serum | 18589210 |
| RLID:11002436 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11002437 | Exosome | Breast milk | 22211110 |
| RLID:11002438 | Exosome | Brain tissue | 23382797 |
| RLID:11002439 | Exosome | Plasma | 23663360 |
| RLID:11002440 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000118 | Exosome | Blood|B lymphoblastoid cells|Seminal fluid | |
| RLID-D:11000408 | Microvesicle | Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-363-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-43888 |
| MNDR | hsa-miR-363-3p | Oral squamous cell carcinoma | MNDR-E-MI-43889 |
| MNDR | hsa-miR-363-3p | Medulloblastoma | MNDR-E-MI-43890 |
| MNDR | hsa-miR-363-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-43891 |
| MNDR | hsa-miR-363-3p | Lymphoma | MNDR-E-MI-43892 |
| MNDR | hsa-miR-363-3p | Non-hodgkin lymphoma | MNDR-E-MI-43893 |
| MNDR | hsa-miR-363-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-43894 |
| MNDR | hsa-miR-363-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-43895 |
| MNDR | hsa-miR-363-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-43896 |
| MNDR | hsa-miR-363-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-43897 |
| MNDR | hsa-miR-363-3p | Her2-receptor positive breast cancer | MNDR-E-MI-43898 |
| MNDR | hsa-miR-363-3p | Breast cancer luminal | MNDR-E-MI-43899 |
| MNDR | hsa-miR-363-3p | Prostate cancer | MNDR-E-MI-43900 |
| MNDR | hsa-miR-363-3p | Gastric cancer | MNDR-E-MI-43901 |
| MNDR | hsa-miR-363-3p | Alzheimer disease | MNDR-E-MI-43902 |
| MNDR | hsa-miR-363-3p | Intracranial aneurysm | MNDR-E-MI-43903 |
| MNDR | hsa-miR-363-3p | Esophageal carcinoma | MNDR-E-MI-43904 |
| MNDR | hsa-miR-363-3p | Dysautonomia familial | MNDR-E-MI-43905 |
| MNDR | hsa-miR-363-3p | Seizures | MNDR-E-MI-43906 |
| MNDR | hsa-miR-363-3p | Head and neck cancer | MNDR-E-MI-43907 |
| MNDR | hsa-miR-363-3p | Leukemia | MNDR-E-MI-43908 |
| MNDR | hsa-miR-363-3p | Friedreich ataxia | MNDR-E-MI-43909 |
| MNDR | hsa-miR-363-3p | Huntington disease | MNDR-E-MI-43910 |
| MNDR | hsa-miR-363-3p | Chorea | MNDR-E-MI-43911 |
| MNDR | hsa-miR-363-3p | Cardiovascular disease | MNDR-E-MI-43912 |
| MNDR | hsa-miR-363-3p | Lung cancer | MNDR-E-MI-43913 |
| MNDR | hsa-miR-363-3p | Down syndrome | MNDR-E-MI-43914 |
| MNDR | hsa-miR-363-3p | Parkinson disease | MNDR-E-MI-43915 |
| MNDR | hsa-miR-363-3p | Basal-like breast cancer | MNDR-E-MI-43916 |
| MNDR | hsa-miR-363-3p | Thyroid cancer | MNDR-E-MI-43917 |
| MNDR | hsa-miR-363-3p | Pituitary neoplasms | MNDR-E-MI-43918 |
| MNDR | hsa-miR-363-3p | Pancreatic cancer | MNDR-E-MI-43919 |
| MNDR | hsa-miR-363-3p | Melanoma | MNDR-E-MI-43920 |
| MNDR | hsa-miR-363-3p | Rectum adenocarcinoma | MNDR-E-MI-43921 |
| MNDR | hsa-miR-363-3p | Nephroblastoma | MNDR-E-MI-43922 |
| MNDR | hsa-miR-363-3p | Colon cancer | MNDR-E-MI-43923 |
| MNDR | hsa-miR-363-3p | Colon adenocarcinoma | MNDR-E-MI-43924 |
| MNDR | hsa-miR-363-3p | West nile virus infection | MNDR-E-MI-43925 |
| MNDR | hsa-miR-363-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-43926 |
| MNDR | hsa-miR-363-3p | Familial ovarian cancer | MNDR-E-MI-43927 |
| MNDR | hsa-miR-363-3p | Prostate adenocarcinoma | MNDR-E-MI-43928 |
| MNDR | hsa-miR-363-3p | Glioblastoma | MNDR-E-MI-43929 |
| MNDR | hsa-miR-363-3p | Astrocytoma | MNDR-E-MI-43930 |
| MNDR | hsa-miR-363-3p | Glioma | MNDR-E-MI-43931 |
| MNDR | hsa-miR-363-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-43932 |
| MNDR | hsa-miR-363-3p | Osteosarcoma | MNDR-E-MI-43933 |
| MNDR | hsa-miR-363-3p | Liposarcoma | MNDR-E-MI-43934 |
| MNDR | hsa-miR-363-3p | Cervical adenocarcinoma | MNDR-E-MI-43935 |
| MNDR | hsa-miR-363-3p | Gastric adenocarcinoma | MNDR-E-MI-43936 |
| MNDR | hsa-miR-363-3p | Cervical squamous cell carcinoma | MNDR-E-MI-43937 |
| MNDR | hsa-miR-363-3p | Pituitary adenoma | MNDR-E-MI-43938 |
| MNDR | hsa-miR-363-3p | Lung squamous cell carcinoma | MNDR-E-MI-43939 |
| MNDR | hsa-miR-363-3p | Lung adenocarcinoma | MNDR-E-MI-43940 |
| MNDR | hsa-miR-363-3p | Thyroid carcinoma | MNDR-E-MI-43941 |
| MNDR | hsa-miR-363-3p | Brain stem cancer | MNDR-E-MI-43942 |
| MNDR | hsa-miR-363-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-43943 |
| MNDR | hsa-miR-363-3p | Carcinoma renal cell | MNDR-E-MI-43944 |
| MNDR | hsa-miR-363-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-43945 |
| MNDR | hsa-miR-363-3p | Clear cell renal cell carcinoma | MNDR-E-MI-43946 |
| MNDR | hsa-miR-363-3p | Cholangiocarcinoma | MNDR-E-MI-43947 |
| MNDR | hsa-miR-363-3p | Esophageal cancer | MNDR-E-MI-43948 |
| MNDR | hsa-miR-363-3p | Oncocytoma | MNDR-E-MI-43949 |
| MNDR | hsa-miR-363-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-43950 |
| MNDR | hsa-miR-363-3p | Testicular germ cell cancer | MNDR-E-MI-43951 |
| MNDR | hsa-miR-363-3p | T acute lymphoblastic leukemia | MNDR-E-MI-43952 |
| MNDR | hsa-miR-363-3p | Acute t cell leukemia | MNDR-E-MI-43953 |
| MNDR | hsa-miR-363-3p | Hepatocellular carcinoma | MNDR-E-MI-43954 |
| MNDR | hsa-miR-363-3p | Embryonal cancer | MNDR-E-MI-43955 |
| MNDR | hsa-miR-363-3p | Familiar ovarian carcinoma | MNDR-E-MI-43956 |
| MNDR | hsa-miR-363-3p | B-cell lymphoma | MNDR-E-MI-43957 |
| MNDR | hsa-miR-363-3p | Rheumatoid arthritis | MNDR-E-MI-43958 |
| MNDR | hsa-miR-363-3p | Retinoblastoma | MNDR-E-MI-43959 |
| MNDR | hsa-miR-363-3p | Barrett's adenocarcinoma | MNDR-E-MI-43960 |
| MNDR | hsa-miR-363-3p | Hodgkin lymphoma | MNDR-E-MI-43961 |
| MNDR | hsa-miR-363-3p | Neuromyelitis optica | MNDR-E-MI-43962 |
| MNDR | hsa-miR-363-3p | Colorectal cancer | MNDR-E-MI-43963 |
| MNDR | hsa-miR-363-3p | Nasopharynx carcinoma | MNDR-E-MI-43964 |
| MNDR | hsa-miR-363-3p | Multiple myeloma | MNDR-E-MI-43965 |
| MNDR | hsa-miR-363-3p | Nasopharyngeal cancer | MNDR-E-MI-43966 |
| MNDR | hsa-miR-363-3p | Wounds and injuries | MNDR-E-MI-43967 |
| MNDR | hsa-miR-363-3p | Epstein-barr virus infections | MNDR-E-MI-43968 |
| MNDR | hsa-miR-363-3p | Gait ataxia | MNDR-E-MI-43969 |
| MNDR | hsa-miR-363-3p | Stroke lacunar | MNDR-E-MI-43970 |
| MNDR | hsa-miR-363-3p | Barrett's carcinogenesis | MNDR-E-MI-43971 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCC1 | Homo sapiens | RR00023318 |
TOP